EphB4 Inhibition Regulates Tumor Microenvironment by Promoting Immunogenic Cell Death Effector Mechanism in Breast Cancer
This study demonstrates that inhibiting EphB4 in breast cancer promotes immunogenic cell death and alters glucose metabolism via the Src/STAT3/MYC pathway, thereby transforming the tumor microenvironment from "cold" to "hot" and enhancing the efficacy of immunotherapy.